Targeting key players in lipid biosynthesis for NAFLD and NASH treatment.

Cell Mol Biol (Noisy-le-grand)

Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Published: November 2024

Undoubtedly, nonalcoholic fatty liver disease (NAFLD) is widely recognized as one of the most prevalent liver diseases worldwide, encompassing a broad spectrum from simple steatosis to the most advanced stage of nonalcoholic steatohepatitis (NASH). However, effective treatments for NAFLD and NASH have not yet been clearly defined. Using appropriate terms such as "Nonalcoholic Fatty Liver Disease", "NAFLD treatment", "Lipid metabolism", "lipid biosynthesis", autophagy "bFGF" and TFG-b" apoptosis, we searched for relevant articles in the PubMed and Scopus databases. This review will discuss the role of the most important players in controlling lipid biosynthesis and lipid metabolism imperfection, which leads to NASH and NAFLD. Furthermore, potential pharmacological agents for targeting molecules and signaling pathways involved in liver inflammation, fibrosis, and cell death are also discussed.

Download full-text PDF

Source
http://dx.doi.org/10.14715/cmb/2024.70.10.17DOI Listing

Publication Analysis

Top Keywords

lipid biosynthesis
8
nafld nash
8
fatty liver
8
targeting key
4
key players
4
players lipid
4
nafld
4
biosynthesis nafld
4
nash
4
nash treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!